Establishment of Japanese-originated comprehensive biomarker system for diagnosis and stratification of patients with various types of dementias based on multicenter alliance for brain biomarkers (MABB)

Establishment of Japanese-originated comprehensive biomarker system for diagnosis and stratification of patients with various types of dementias based on multicenter alliance for brain biomarkers (MABB) - Research on dementia sponsored by AMED

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047214

Enrollment

240

Registered

2022-03-22

Start date

2022-05-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients of 20 years and over 2) Written informed consent can be obtained from patients or proxies. 3) Patients with MCI due to the following diseases: (1)Alzheimer's disease (2)corticobasal degeneration (3)progressive supranuclear palsy (4)frontotemporal lobar degeneration (5)Parkinson's disease (6)dmentia with Lewy bodies (7)Kii-ALS-parkinsonism-dementia complex (8)myotonic dystrophy (9)diffuse neurofibrillary tangles with calcification (10)idiopathic normal pressure hydrocephalus (11)amyotrophic lateral sclerosis (ALS) (12)multiple system atrophy etc.

Exclusion criteria

Exclusion criteria: 1) Patients who have organic brain diseases 2) Patients who have drug dependence 3) Patients who have a serious illness 4) Patients who have claustrophobia 5) Patients during the period of pregnancy and lactation 6) Patients who the researchers consider unsuitable for the research participants

Design outcomes

Primary

Measure	Time frame
Not applicable because it is an observational study	—

Countries

Japan

Contacts

Public ContactTakahiko Tokuda

National Institutes for Quantum and Radiological Science and Technology (QST) Department of Functional Brain Imaging Research

ttokuda022160@gmail.com043-206-3249

Outcome results